Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri Lavillette

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Journal of Virology|April 29, 2005
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionDimitri Lavillette, Yoann Morice, Georgios Germanidis, et al.
Hepatology (Baltimore, Md.)|January 22, 2005
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virusDimitri Lavillette, Alexander W Tarr, Cécile Voisset, et al.
Plos Pathogens|February 21, 2009
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsMarlène Dreux, Viet Loan Dao Thi, Judith Fresquet, et al.
AIDS (London, England)|July 1, 2015
Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patientsGuillemette Maurin, Boris Halgand, Patrice Bruscella, et al.
Plos One|February 2, 2011
Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidolElodie Teissier, Giorgia Zandomeneghi, Antoine Loquet, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2015
A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation StatusFloriane Fusil, Sara Calattini, Fouzia Amirache, et al.
International Journal of Biological Macromolecules|April 23, 2022
Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2Tingting Li, Bingjie Zhou, Yaning Li, et al.
Journal of Virology|June 12, 2009
The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infectionIgnacio Benedicto, Francisca Molina-Jiménez, Birke Bartosch, et al.
Frontiers in Microbiology|June 20, 2022
Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 VariantsTingting Li, Bingjie Zhou, Zhipu Luo, et al.
Journal of Virology|October 24, 2014
The sheep tetherin paralog oBST2B blocks envelope glycoprotein incorporation into nascent retroviral virionsLita Murphy, Mariana Varela, Sophie Desloire, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Journal of Virology|April 29, 2005
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionDimitri Lavillette, Yoann Morice, Georgios Germanidis, et al.
Hepatology (Baltimore, Md.)|January 22, 2005
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virusDimitri Lavillette, Alexander W Tarr, Cécile Voisset, et al.
Plos Pathogens|February 21, 2009
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domainsMarlène Dreux, Viet Loan Dao Thi, Judith Fresquet, et al.
AIDS (London, England)|July 1, 2015
Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patientsGuillemette Maurin, Boris Halgand, Patrice Bruscella, et al.
Plos One|February 2, 2011
Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidolElodie Teissier, Giorgia Zandomeneghi, Antoine Loquet, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2015
A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation StatusFloriane Fusil, Sara Calattini, Fouzia Amirache, et al.
International Journal of Biological Macromolecules|April 23, 2022
Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2Tingting Li, Bingjie Zhou, Yaning Li, et al.
Journal of Virology|June 12, 2009
The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infectionIgnacio Benedicto, Francisca Molina-Jiménez, Birke Bartosch, et al.
Frontiers in Microbiology|June 20, 2022
Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 VariantsTingting Li, Bingjie Zhou, Zhipu Luo, et al.
Journal of Virology|October 24, 2014
The sheep tetherin paralog oBST2B blocks envelope glycoprotein incorporation into nascent retroviral virionsLita Murphy, Mariana Varela, Sophie Desloire, et al.
Pageof 8